Patents by Inventor Mitsuaki Kawamura

Mitsuaki Kawamura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210154122
    Abstract: A composition for external use is provided, comprising a phosphate ester of uridine or a physiologically acceptable salt thereof as an active ingredient for moisturizing, anti-wrinkling, anti-sagging, wound healing, prevention of hair loss, hair growth, or prevention/treatment of atopic dermatitis.
    Type: Application
    Filed: July 23, 2018
    Publication date: May 27, 2021
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Mitsuaki KAWAMURA, Masahiko TANAKA, Sachiyo IGARASHI
  • Patent number: 9125928
    Abstract: An object of the present invention is to provide an agent for suppressing the formation of skin cells induced by exposure to light such as ultraviolet light. The object is achieved by using a purine nucleic acid for suppressing the formation of abnormal skin cells caused by exposure to light.
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: September 8, 2015
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Mitsuaki Kawamura, Shigeo Shinohara, Fumiki Harano, Akihiro Aoki, Eri Ueno
  • Publication number: 20130090301
    Abstract: An object of the present invention is to provide an agent for suppressing the formation of skin cells induced by exposure to light such as ultraviolet light. The object is achieved by using a purine nucleic acid for suppressing the formation of abnormal skin cells caused by exposure to light.
    Type: Application
    Filed: June 24, 2011
    Publication date: April 11, 2013
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Mitsuaki Kawamura, Shigeo Shinohara, Fumiki Harano, Akihiro Aoki, Eri Ueno
  • Patent number: 7994153
    Abstract: The present invention provides a composition that can effectively improve melasma and a composition that can effectively reduce skin dullness. The composition for improving melasma comprises a purine nucleic acid-related substance and a pharmaceutically or cosmetically acceptable carrier, and exhibits an excellent melasma improving effect due to the action of the purine nucleic acid-related substance contained. The composition for reducing skin dullness comprises a purine nucleic acid-related substance and a pharmaceutically or cosmetically acceptable carrier, and exhibits an excellent effect of reducing skin dullness due to the action of the purine nucleic acid-related substance contained.
    Type: Grant
    Filed: May 19, 2003
    Date of Patent: August 9, 2011
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Hideo Tanaka, Masahiko Tanaka, Yasuo Furuta, Kosaburo Wakamatsu, Junko Kamimura, Fumiki Harano, Mitsuaki Kawamura, Shigekatsu Kawabata, Shigeo Shinohara, Noboru Yoshino
  • Patent number: 7794739
    Abstract: A method for effectively exerting a cell proliferation promoting effect of a purine nucleic acid-related substance, and a composition for cell proliferation containing a purine nucleic acid-related substance and a pyrimidine nucleic acid-related substance. Also a method for potentiating the cell proliferation promoting effect of the purine nucleic acid-related substance by using the purine nucleic acid-related substance in combination with the pyrimidine nucleic acid-related substance and a method for promoting cell proliferation, where the method includes the step of applying the purine nucleic acid-related substance in combination with the pyrimidine nucleic acid-related substance to the skin or mucosa.
    Type: Grant
    Filed: April 3, 2003
    Date of Patent: September 14, 2010
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Mitsuaki Kawamura, Shigeo Shinohara
  • Patent number: 7557093
    Abstract: The invention provides a composition for promoting collagen production, and more specifically, provides a composition capable of promoting collagen production in human dermis. Further, the invention provides a method for promoting collagen production. The invention provides a composition for promoting collagen production containing a purine nucleic acid-related substance as an active ingredient as well as a composition for promoting collagen production containing a purine nucleic acid-related substance and a pyrimidine nucleic acid-related substance. The method for promoting collagen production of the invention comprises applying a purine nucleic acid-related substance alone or in combination with a pyrimidine nucleic acid-related substance to the skin.
    Type: Grant
    Filed: October 8, 2004
    Date of Patent: July 7, 2009
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Shigeo Shinohara, Mitsuaki Kawamura
  • Publication number: 20070135374
    Abstract: The invention provides a composition for promoting collagen production, and more specifically, provides a composition capable of promoting collagen production in human dermis. Further, the invention provides a method for promoting collagen production. The invention provides a composition for promoting collagen production containing a purine nucleic acid-related substance as an active ingredient as well as a composition for promoting collagen production containing a purine nucleic acid-related substance and a pyrimidine nucleic acid-related substance. The method for promoting collagen production of the invention comprises applying a purine nucleic acid-related substance alone or in combination with a pyrimidine nucleic acid-related substance to the skin.
    Type: Application
    Filed: October 8, 2004
    Publication date: June 14, 2007
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Shigeo Shinohara, Mitsuaki Kawamura
  • Publication number: 20050220827
    Abstract: The present invention provides a composition that can effectively improve melasma and a composition that can effectively reduce skin dullness. The composition for improving melasma comprises a purine nucleic acid-related substance and a pharmaceutically or cosmetically acceptable carrier, and exhibits an excellent melasma improving effect due to the action of the purine nucleic acid-related substance contained. The composition for reducing skin dullness comprises a purine nucleic acid-related substance and a pharmaceutically or cosmetically acceptable carrier, and exhibits an excellent effect of reducing skin dullness due to the action of the purine nucleic acid-related substance contained.
    Type: Application
    Filed: May 19, 2003
    Publication date: October 6, 2005
    Inventors: Hideo Tanaka, Masahiko Tanaka, Yasuo Furuta, Kosaburo Wakamatsu, Junko Kamimura, Fumiki Harano, Mitsuaki Kawamura, Shigekatsu Kawabata, Shigeo Shinohara, Noboru Yoshino
  • Publication number: 20050222076
    Abstract: The present invention provides a method for effectively exerting a cell proliferation promoting effect of a purine nucleic acid-related substance. The present invention provides a composition for cell proliferation containing a purine nucleic acid-related substance and a pyrimidine nucleic acid-related substance. Further, the present invention provides a method for potentiating the cell proliferation promoting effect of the purine nucleic acid-related substance by using the purine nucleic acid-related substance in combination with the pyrimidine nucleic acid-related substance. Still further, the present invention provides a method for promoting cell proliferation, where the method comprising applying purine nucleic acid-related substance in combination with the pyrimidine nucleic acid-related substance to the skin or mucosa.
    Type: Application
    Filed: April 3, 2003
    Publication date: October 6, 2005
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Mitsuaki Kawamura, Shigeo Shinohara